Doctronic reports that Tamiflu (oseltamivir) is an antiviral for flu treatment and prevention, with dosage varying by age, ...

Tirzepatide, an injection medication already approved by the Food and Drug Administration (FDA) to treat Type 2 diabetes, is likely to receive FDA approval for another indication — weight loss — later ...

Cipro (ciprofloxacin) is a brand-name drug prescribed for certain bacterial infections in adults and some children. Cipro comes in several forms and is typically taken every 12 hours. The dosage can ...

In addition to an injection given under your skin, Imitrex is also available as an oral tablet and a nasal spray. Imitrex belongs to a group of drugs called triptans. This article describes the ...

Farxiga is a prescription oral tablet used to manage type 2 diabetes or certain heart or kidney conditions. It’s a brand-name drug with the active ingredient dapagliflozin. Farxiga tablets come in ...

Humalog is given as an injection, and there are two types of the drug: Some forms of Humalog and Humalog Mix are available as generics or biosimilars. To learn more, see “Generic or biosimilar ...

Drug names often draw curiosity and confusion—and they always get a once-over by the FDA. The agency is more than usually interested these days, though. After a round of new guidance issued in ...

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

46 new molecular entities cleared the agency’s hurdles last year, 4 fewer than in 2024 ...

XtalPi is a quantum-physics, AI-powered Research and Development company based in Cambridge, MA, with branches in China. They are breaking barriers by being fairly early to hop into drug discovery ...

The combination of Imfinzi with chemotherapy dramatically reduced the risk of death from extensive-stage small-cell lung cancer compared with chemotherapy alone. China's approval of an additional ...

Officials for the FDA have expanded its’ approval of pimobendan chewable tablets (Vetmedin; Boehringer Ingelheim) to include a new indication. The drug is now approved for delay of congestive heart ...